4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001764013-26-000077
Chief Executive Officer sold 3,092 shares at $38.48 ($118,980)
- Chief Executive Officer returned 86,629 shares (to the company)
- Chief Executive Officer acquired 92,188 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Venker Eric Chief Executive Officer | 2026-07-01 | Option exercise | +92,188 | $14.46 | $1,333,038 | 344,001 | D |
| Venker Eric Chief Executive Officer | 2026-07-01 | Returned to the company | −86,629 | $38.14 | $3,304,030 | 257,372 | D |
| Venker Eric Chief Executive Officer | 2026-07-02 | Sale | −3,092 | $38.48 | $118,980 | 254,280 | D |
| Derivatives | |||||||
| Venker Eric Chief Executive Officer | 2026-07-01 | Option exercise · Capped Value Appreciation Rights | −92,188 | 1,014,062 | D | ||
| Open-market sales · 3,092 sh · avg $38.48 · $118,980 | |||||||
Loading xslF345X06/wk-form4_1783371682.xml…